Vivimed Labs Ltd
Vivimed Labs Ltd (VIVIMEDLAB) last traded at ₹6.68, a market capitalisation of ₹55.4 crore. Over the past 52 weeks the stock has ranged between ₹4.75 and ₹29.4. Vivimed Labs Ltd last reported results for the quarter ended Mar 2026, with sales of ₹12 crore and net profit of ₹-147 crore. Figures are as of 25 Aug 2026 and are not real time.
Vivimed Labs Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Vivimed Labs Ltd quarterly results
In the quarter ended Mar 2026, sales were ₹12 cr, down 53.8% from ₹26 cr a year earlier. Net profit was ₹-147 cr, down 2350.0% year on year.
| ₹ crore | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 29 | 25 | 37 | 26 | 21 | 21 | 16 | 12 |
| Expenses | 40 | 25 | 35 | 28 | 22 | 22 | 27 | 152 |
| Operating profit | -11 | -1 | 1 | -2 | -0 | -1 | -11 | -140 |
| OPM % | -37% | -2.6% | 2.9% | -10% | -1.3% | -4.6% | -68% | -1,169% |
| Other income | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 6 |
| Interest | 0 | 0 | 0 | 2 | 1 | 2 | 1 | 1 |
| Depreciation | 4 | 4 | 7 | 6 | 5 | 5 | 5 | 12 |
| Profit before tax | -15 | -5 | -6 | -5 | -5 | -7 | -17 | -147 |
| Tax % | 0% | 0% | 0% | 2% | 0% | 0% | 0% | 0% |
| Net profit | -15 | -5 | -6 | -6 | -5 | -7 | -17 | -147 |
| EPS (₹) | -1.84 | -0.62 | -0.72 | -0.68 | -0.66 | -0.88 | -2.00 | -17.74 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Vivimed Labs Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 861 | 237 | 187 | 149 | 116 | 70 |
| Operating profit | 32 | -8 | -187 | -33 | -13 | -152 |
| OPM % | 3.7% | -3.3% | -100% | -22% | -11% | -218% |
| Net profit | -72 | -68 | -329 | -45 | -32 | -176 |
| EPS (₹) | -8.67 | -8.16 | -39.62 | -5.48 | -3.85 | -21.28 |
TTM is the trailing twelve months to the most recent quarter.
Vivimed Labs Ltd growth and returns
- 10 Years
- -26%
- 5 Years
- -39%
- 3 Years
- -28%
- TTM
- -40%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 14%
- TTM
- -452%
- 10 Years
- -22%
- 5 Years
- -21%
- 3 Years
- 10%
- 1 Year
- %
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- %
Vivimed Labs Ltd shareholding pattern
Promoters held 7.57% at Mar 2026, down from 20.94% at Mar 2025. FIIs 1.64%.
| % held | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 20.94% | 20.94% | 20.94% | 20.94% | 7.76% | 7.76% | 7.76% | 7.57% |
| FIIs | 1.64% | 1.64% | 1.64% | 1.64% | 1.64% | 1.64% | 1.64% | 1.64% |
| Government | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% |
| Public | 77.30% | 77.30% | 77.30% | 77.30% | 90.47% | 90.47% | 90.47% | 90.66% |
| No. of shareholders | 49,012 | 49,003 | 49,005 | 48,957 | 48,928 | 48,925 | 49,221 | 47,492 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Vivimed Labs Ltd corporate filings
- 6th COC meeting on 18th August 2026Company Updatelow impact
Cruxal's analysis: Vivimed Labs, currently undergoing Corporate Insolvency Resolution Process (CIRP), has…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Vivimed Labs Ltd
Cruxal reads every Vivimed Labs Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.